Table of Contents
Abstracts: AACR Special Conference: Targeting the PI3K-mTOR Network in Cancer; September 14-17, 2014; Philadelphia, PA
Clinical Data with PI3K and mTOR Inhibitors
Molecular Regulation of the PI3K-mTOR Network
Opening Plenary Session
PI3K-mTOR Activation in Human Cancer
Preclinical and Clinical Studies in Breast Cancer
Preclinical Models of PI3K-driven Cancers
Resistance Mechanisms
The PI3K-mTOR Network in Hematopoetic Cancers
July 2015
Volume 14, Issue 7 Supplement
Volume 14, Issue 7 Supplement
Jump to
- Clinical Data with PI3K and mTOR Inhibitors
- Downstream Effectors Underlying Cancer Progression
- Molecular Regulation of the PI3K-mTOR Network
- Opening Plenary Session
- PI3K-mTOR Activation in Human Cancer
- Preclinical and Clinical Studies in Breast Cancer
- Preclinical Models of PI3K-driven Cancers
- Resistance Mechanisms
- The PI3K-mTOR Network in Hematopoetic Cancers
- Other Topics
Advertisement
